Risk factors predicting progression of diabetic retinopathy over six years in 1579 NIDDM patients

Risk factors predicting progression of diabetic retinopathy over six years in 1579 NIDDM patients

Detalhes bibliográficos
Principais autores:	Stratton, I, Kohner, E, Matthews, DR, Holman, R, Aldington, S, Turner, R
Formato:	Journal article
Publicado em:	1996

Registros relacionados

PROGRESSION OF DIABETIC-RETINOPATHY OVER 6 YEARS IN PATIENTS STUDIED IN THE UK PROSPECTIVE DIABETES STUDY
por: Aldington, S, et al.
Publicado em: (1994)

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.
por: Stratton, I, et al.
Publicado em: (2001)

Nine-year status of diabetic retinopathy and photocoagulation in the UK prospective diabetes study.
por: Aldington, S, et al.
Publicado em: (1996)

PROGRESSION OF DIABETIC-RETINOPATHY IN TYPE-2 DIABETIC-PATIENTS IN THE UK PROSPECTIVE DIABETES STUDY
por: Stratton, I, et al.
Publicado em: (1993)

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).
por: Kohner, E, et al.
Publicado em: (2001)

RETINOPATHY IN THE UKPDS TRIAL MICRO-ANEURYSM COUNTS AND THE RISKS OF PROGRESSION OVER 3-YEARS AND 6-YEARS
por: Matthews, D, et al.
Publicado em: (1995)

Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
por: Matthews, DR, et al.
Publicado em: (2004)

Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group.
por: Kohner, E, et al.
Publicado em: (1999)

United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors.
por: Kohner, E, et al.
Publicado em: (1998)

PREVALENCE OF RETINOPATHY AT DIAGNOSIS OF TYPE-II DIABETES IN THE UK PROSPECTIVE DIABETES STUDY
por: Kohner, E, et al.
Publicado em: (1993)

PREVALENCE OF DIABETIC-RETINOPATHY AT DIAGNOSIS OF NON-INSULIN-DEPENDENT DIABETES IN THE UNITED-KINGDOM PROSPECTIVE DIABETES STUDY
por: Kohner, E, et al.
Publicado em: (1993)

PREVALENCE OF DIABETIC-RETINOPATHY AT DIAGNOSIS OF NON-INSULIN-DEPENDENT DIABETES IN 2964 WHITE CAUCASIAN SUBJECTS AND ASSOCIATION WITH HYPERTENSION, HYPERGLYCEMIA AND IMPAIRED BETA-CELL FUNCTION
por: Stratton, I, et al.
Publicado em: (1995)

Effects of ethnicity on metabolic control during the first six years of NIDDM
por: Davis, T, et al.
Publicado em: (1997)

Evaluating risk of progression to photocoagulation by retinal photography or direct ophthalmoscopy.
por: Stratton, I, et al.
Publicado em: (1997)

U.K. Prospective Diabetes Study 22. Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM.
por: Davis, T, et al.
Publicado em: (1997)

Treatment of NIDDM - Progressive requirement for polypharmacy to attain glycaemic goals
por: Cull, C, et al.
Publicado em: (1997)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
por: Matthews, DR, et al.
Publicado em: (1998)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
por: Matthews, DR, et al.
Publicado em: (1998)

Glycaemic improvement over one year in a double-blind trial of acarbose in 1,946 NIDDM patients
por: Holman, R, et al.
Publicado em: (1996)

UK prospective diabetes study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM.
por: Keavney, B, et al.
Publicado em: (1995)

Risk factors for presence of hard exudates at diagnosis of Type 2 diabetes and after 6 years.
por: Stratton, J, et al.
Publicado em: (2003)

Insulin use in NIDDM. Rationale based on pathophysiology of disease.
por: Turner, R, et al.
Publicado em: (1990)

No glycemic benefit from guar administration in NIDDM.
por: Holman, R, et al.
Publicado em: (1987)

CIGMA as a tool in the study of NIDDM.
por: Turner, R, et al.
Publicado em: (1988)

UK PROSPECTIVE DIABETES STUDY 16 - OVERVIEW OF 6 YEARS THERAPY OF TYPE-II DIABETES - A PROGRESSIVE DISEASE
por: Turner, R, et al.
Publicado em: (1995)

The influence of background diabetic retinopathy in the second eye on rates of progression of diabetic retinopathy between 2005 and 2010.
por: Scanlon, P, et al.
Publicado em: (2013)

Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy.
por: Scanlon, P, et al.
Publicado em: (2014)

Coronary heart disease and risk factors in NIDDM--experience from the United Kingdom Prospective Diabetes Study.
por: Turner, R, et al.
Publicado em: (1997)

Epidemiological issues in diabetic retinopathy.
por: Scanlon, P, et al.
Publicado em: (2013)

Pathogenesis of NIDDM--a disease of deficient insulin secretion.
por: Turner, R, et al.
Publicado em: (1988)

Sulphonylurea therapy over six years does not delay progression to diabetes
por: Herlihy, O, et al.
Publicado em: (2000)

U.K. Prospective Diabetes Study. XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM.
por: Dudley, C, et al.
Publicado em: (1995)

A Practical Manual of Diabetic Retinopathy Management
por: Scanlon, P, et al.
Publicado em: (2009)

Personalised risk estimation for progression to sight-threatening diabetic retinopathy: how much does clinical information add to screening data?
por: Stratton, I, et al.
Publicado em: (2014)

Post-prandial amylin concentrations are increased by sulphonylurea, but unchanged by basal insulin, in NIDDM
por: Rachman, J, et al.
Publicado em: (1996)

Segregation analysis of NIDDM in Caucasian families.
por: Cook, J, et al.
Publicado em: (1994)

STUDY DESIGN OF THE UK PROSPECTIVE DIABETES STUDY AND PROGRESS OF EYE DATA
por: Stratton, I, et al.
Publicado em: (1993)

Reinforced healthy living advice over six years does not delay progression to diabetes
por: Dyson, P, et al.
Publicado em: (2000)

Thyroid dysfunction and its relation with diabetes mellitus (NIDDM)
por: H.R.Bazrafshan (M.D), et al.
Publicado em: (2000-03-01)

Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
por: Rachman, J, et al.
Publicado em: (1998)